Shares of Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) have received a consensus recommendation of “Hold” from the seven research firms that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a strong buy rating to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $6.42.
Several equities analysts have recently weighed in on CDLX shares. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a report on Thursday, March 13th. Lake Street Capital decreased their target price on Cardlytics from $5.00 to $3.00 and set a “hold” rating for the company in a research report on Thursday, March 13th. Finally, Evercore ISI cut their price target on Cardlytics from $4.00 to $3.00 and set an “in-line” rating on the stock in a report on Thursday, March 13th.
View Our Latest Report on CDLX
Cardlytics Stock Down 1.0 %
Insider Activity at Cardlytics
In other Cardlytics news, CEO Amit Gupta sold 46,857 shares of the firm’s stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total transaction of $159,313.80. Following the transaction, the chief executive officer now directly owns 418,637 shares in the company, valued at approximately $1,423,365.80. This trade represents a 10.07 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Alexis Desieno sold 8,854 shares of Cardlytics stock in a transaction on Friday, January 3rd. The stock was sold at an average price of $3.67, for a total transaction of $32,494.18. Following the transaction, the chief financial officer now directly owns 121,976 shares in the company, valued at $447,651.92. This represents a 6.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 111,454 shares of company stock valued at $391,864. 4.40% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the company. Two Sigma Advisers LP increased its stake in Cardlytics by 44.1% in the 4th quarter. Two Sigma Advisers LP now owns 36,900 shares of the company’s stock valued at $137,000 after buying an additional 11,300 shares during the last quarter. Two Sigma Investments LP grew its holdings in shares of Cardlytics by 12.5% in the fourth quarter. Two Sigma Investments LP now owns 94,901 shares of the company’s stock valued at $352,000 after acquiring an additional 10,508 shares in the last quarter. ProShare Advisors LLC purchased a new stake in shares of Cardlytics during the fourth quarter valued at approximately $43,000. Millennium Management LLC bought a new stake in Cardlytics during the fourth quarter worth $535,000. Finally, D. E. Shaw & Co. Inc. boosted its position in Cardlytics by 97.4% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 1,131,505 shares of the company’s stock worth $4,198,000 after purchasing an additional 558,235 shares during the last quarter. 68.10% of the stock is owned by institutional investors.
Cardlytics Company Profile
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Read More
- Five stocks we like better than Cardlytics
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellĀ
- How to Use the MarketBeat Excel Dividend Calculator
- Top 3 Beverage Stocks Pouring Out Profits
- Do ETFs Pay Dividends? What You Need to Know
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.